Âé¶ą´«Ă˝É«ÇéƬ

Annual Meeting

Biochemists face the climate challenge

Learn about the Discover BMB 2024 symposium by the Maximizing Access Committee
Karla Neugebauer Kayunta Johnson–Winters
By Karla Neugebauer and Kayunta Johnson–Winters
Sept. 14, 2023

Everyone knows coral bleaching occurs when seawater gets hot. Biochemists ask: How?

Corals die when their photosynthetic algal symbionts experience heat stress and exude hydrogen peroxide, causing coral tissue to expel the algae. Thus, coral bleaching is a biochemical process that we can understand and engage with, imagining new solutions to climate changes that degrade our planet.

Submit an abstract

Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30.

The Centers for Disease Control and Prevention have long embraced “One Health,” the concept that a healthy planet is required for human health. Recently, the National Institutes of Health launched their Climate Change and Health Initiative. Biochemistry is central to preserving the natural world and developing fully renewable building materials, novel foods and health care solutions.

This session will explore how the living world experiences changes in temperature, pH, salt, nutrients, desiccation and other conditions. The speakers will illuminate the cell and molecular mechanisms underlying coral symbiosis, thermal adaptations of marine organisms, temperature-dependent mutagenesis and transposition in the fungal pathogen Cryptococcus neoformans, and the endocrine underpinnings of environmental influences on human health. This session is for the next generation of biochemists who will meet the climate challenge.

Keywords: One Health, thermal adaptation, symbiosis.

Who should attend: The next generation of biochemists who will save the planet.

Theme song: by John Lennon

This session is powered by the courage to face humanity’s greatest challenge.

Biochemistry and climate change

Asiya Gusa, Duke University 

James A. DeMayo, University of Colorado–Denver

Yixian ZhengCarnegie Institution for Science

Teresa HortonNorthwestern University

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Karla Neugebauer
Karla Neugebauer

Karla Neugebauer is a professor of molecular biophysics and biochemistry at Yale University.

Kayunta Johnson–Winters
Kayunta Johnson–Winters

Kayunta Johnson–Winters is an associate professor of chemistry and biochemistry at the University of Texas, Arlington.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Journal News

Receptor antagonist reduces age-related bone loss in mice

Aug. 6, 2025

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Journal News

Engineered fusion protein targets kiwifruit pathogen

Aug. 6, 2025

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.